Supernus Pharmaceuticals (SUPN) Intangibles (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Intangibles of $469.5 million for Q2 2026, down 2.46% year-over-year from $481.3 million in Q2 2025, and down 14.6% on a QoQ basis from $549.7 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Intangibles (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Intangibles for 16 years, with the latest figure at $469.5 million in Q2 2026.
- Intangibles for Q2 2026 came in at $469.5 million, down 2.46% year-over-year; the trailing twelve-month figure through Jun 2026 was $469.5 million (down 2.46% YoY), and the FY2025 annual result was $569.5 million, up 9.11% from the prior year.
- Intangibles retreated to $469.5 million in Q2 2026, from $549.7 million in the prior quarter.
- Over five years, Intangibles peaked at $764.0 million in Q1 2022 and troughed at $469.5 million in Q2 2026.
- A 5-year average of $606.4 million and a median of $589.8 million in 2023 frame the typical range for Intangibles.
- The widest annual swing landed in 2022, when Intangibles surged 112.98%; it then declined 15.75% in 2024.
- A 5-year view of Intangibles shows it stood at $702.5 million in 2022, then fell by 14.6% to $599.9 million in 2023, then fell by 13.0% to $521.9 million in 2024, then advanced by 9.11% to $569.5 million in 2025, then decreased by 17.56% to $469.5 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $469.5 million in Q2 2026, $549.7 million in Q1 2026, and $569.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.12 Bn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn | 469.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 469.46 Mn |
| Mar 31, 2026 | 549.71 Mn |
| Dec 31, 2025 | 569.46 Mn |
| Sep 30, 2025 | 623.48 Mn |
| Jun 30, 2025 | 481.31 Mn |
| Mar 31, 2025 | 502.13 Mn |
| Dec 31, 2024 | 521.91 Mn |
| Sep 30, 2024 | 540.16 Mn |
| Jun 30, 2024 | 559.64 Mn |
| Mar 31, 2024 | 579.75 Mn |
| Dec 31, 2023 | 599.89 Mn |
| Sep 30, 2023 | 641.15 Mn |
| Jun 30, 2023 | 662.39 Mn |
| Mar 31, 2023 | 682.50 Mn |
| Dec 31, 2022 | 702.46 Mn |
| Sep 30, 2022 | 722.76 Mn |
| Jun 30, 2022 | 743.41 Mn |
| Mar 31, 2022 | 764.05 Mn |
| Dec 31, 2021 | 784.69 Mn |
| Sep 30, 2021 | 346.62 Mn |